High Iron Exposure from the Fetal Stage to Adulthood in Mice Alters Lipid Metabolism

Overview

Journal Nutrients

Date 2022 Jun 24

PMID 35745181

Authors

Minju Kim

Yeon-Hee Kim

Sohyun Min

Seung-Min Lee

Affiliations

Soon will be listed here.

Abstract

Iron supplementation is recommended during pregnancy and fetal growth. However, excess iron exposure may increase the risk of abnormal fetal development. We investigated the potential side effects of high iron levels in fetuses and through their adult life. C57BL/6J pregnant mice from 2 weeks of gestation and their offspring until 30 weeks were fed a control (CTRL, FeSO 0 g/1 kg) or high iron (HFe, FeSO 9.9 g/1 kg) diets. HFe group showed higher iron accumulation in the liver with increased hepcidin, reduced TfR1/2 mRNAs, and lowered ferritin heavy chain (FTH) proteins in both liver and adipose tissues despite iron loading. HFe decreased body weight, fat weight, adipocyte size, and triglyceride levels in the blood and fat, along with downregulation of lipogenesis genes, including PPARγ, C/EBPα, SREBP1c, FASN, and SCD1, and fatty acid uptake and oxidation genes, such as CD36 and PPARα. UCP2, adiponectin, and mRNA levels of antioxidant genes such as GPX4, HO-1, and NQO1 were increased in the HFe group, while total glutathione was reduced. We conclude that prolonged exposure to high iron from the fetal stage to adulthood may decrease fat accumulation by altering ferritin expression, adipocyte differentiation, and triglyceride metabolism, resulting in an alteration in normal growth.

Citing Articles

Dose effects of iron on growth, antioxidant potential, intestinal morphology, and intestinal barrier in yellow-feathered broilers.

Chen J, Lei K, Li S, Li D, Wang Y, Wang X Poult Sci. 2025; 104(3):104865.

PMID: 39919560 PMC: 11851222. DOI: 10.1016/j.psj.2025.104865.

L-Citrulline Supplementation Restrains Ferritinophagy-Mediated Ferroptosis to Alleviate Iron Overload-Induced Thymus Oxidative Damage and Immune Dysfunction.

Ba T, Zhao D, Chen Y, Zeng C, Zhang C, Niu S Nutrients. 2022; 14(21).

PMID: 36364817 PMC: 9655478. DOI: 10.3390/nu14214549.

References

Andreelli F, Foretz M, Knauf C, Cani P, Perrin C, Iglesias M . Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin. Endocrinology. 2006; 147(5):2432-41. DOI: 10.1210/en.2005-0898. View

Onyenwoke R, Wiegel J . Iron (III) reduction: A novel activity of the human NAD(P)H:oxidoreductase. Biochem Biophys Res Commun. 2006; 353(2):389-93. DOI: 10.1016/j.bbrc.2006.12.022. View

Zhang M, Liu Y, Shi H, Guo M, Chai M, He Q . Evolutionary and expression analyses of soybean basic Leucine zipper transcription factor family. BMC Genomics. 2018; 19(1):159. PMC: 5824455. DOI: 10.1186/s12864-018-4511-6. View

Vertuani S, Angusti A, Manfredini S . The antioxidants and pro-antioxidants network: an overview. Curr Pharm Des. 2004; 10(14):1677-94. DOI: 10.2174/1381612043384655. View

Laker R, Lillard T, Okutsu M, Zhang M, Hoehn K, Connelly J . Exercise prevents maternal high-fat diet-induced hypermethylation of the Pgc-1α gene and age-dependent metabolic dysfunction in the offspring. Diabetes. 2014; 63(5):1605-11. PMC: 5860829. DOI: 10.2337/db13-1614. View

Courselaud B, Pigeon C, Inoue Y, Inoue J, Gonzalez F, Leroyer P . C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J Biol Chem. 2002; 277(43):41163-70. DOI: 10.1074/jbc.M202653200. View

Moretti D, Goede J, Zeder C, Jiskra M, Chatzinakou V, Tjalsma H . Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood. 2015; 126(17):1981-9. DOI: 10.1182/blood-2015-05-642223. View

Amin S, Myers G, Wang H . Association between neonatal iron overload and early human brain development in premature infants. Early Hum Dev. 2012; 88(8):583-7. PMC: 3677745. DOI: 10.1016/j.earlhumdev.2011.12.030. View

Furuhashi M, Hotamisligil G . Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov. 2008; 7(6):489-503. PMC: 2821027. DOI: 10.1038/nrd2589. View

10.

Koenig M, Tussing-Humphreys L, Day J, Cadwell B, Nemeth E . Hepcidin and iron homeostasis during pregnancy. Nutrients. 2014; 6(8):3062-83. PMC: 4145295. DOI: 10.3390/nu6083062. View

11.

Zhang Q, Lu X, Zhang M, Yang C, Lv S, Li S . Adverse effects of iron deficiency anemia on pregnancy outcome and offspring development and intervention of three iron supplements. Sci Rep. 2021; 11(1):1347. PMC: 7809104. DOI: 10.1038/s41598-020-79971-y. View

12.

Kakhlon O, Gruenbaum Y, Cabantchik Z . Repression of ferritin expression increases the labile iron pool, oxidative stress, and short-term growth of human erythroleukemia cells. Blood. 2001; 97(9):2863-71. DOI: 10.1182/blood.v97.9.2863. View

13.

Jiang S, Yan K, Sun B, Gao S, Yang X, Ni Y . Long-Term High-Fat Diet Decreases Hepatic Iron Storage Associated with Suppressing TFR2 and ZIP14 Expression in Rats. J Agric Food Chem. 2018; 66(44):11612-11621. DOI: 10.1021/acs.jafc.8b02974. View

14.

Ricquier D . Uncoupling protein-2 (UCP2): molecular and genetic studies. Int J Obes Relat Metab Disord. 1999; 23 Suppl 6:S38-42. DOI: 10.1038/sj.ijo.0800942. View

15.

Stordal K, McArdle H, Hayes H, Tapia G, Viken M, Lund-Blix N . Prenatal iron exposure and childhood type 1 diabetes. Sci Rep. 2018; 8(1):9067. PMC: 5998022. DOI: 10.1038/s41598-018-27391-4. View

16.

Thame M, Wilks R, McFarlane-Anderson N, Bennett F, Forrester T . Relationship between maternal nutritional status and infant's weight and body proportions at birth. Eur J Clin Nutr. 1997; 51(3):134-8. DOI: 10.1038/sj.ejcn.1600357. View

17.

Nath I V A, Nair A . Bioinformatics screening of ETV4 transcription factor oncogenes and identifying small-molecular anticancer drugs. Chem Biol Drug Des. 2021; 99(2):277-285. DOI: 10.1111/cbdd.13981. View

18.

Le Lay S, Simard G, Martinez M, Andriantsitohaina R . Oxidative stress and metabolic pathologies: from an adipocentric point of view. Oxid Med Cell Longev. 2014; 2014:908539. PMC: 4131099. DOI: 10.1155/2014/908539. View

19.

Perera F, Herbstman J . Prenatal environmental exposures, epigenetics, and disease. Reprod Toxicol. 2011; 31(3):363-73. PMC: 3171169. DOI: 10.1016/j.reprotox.2010.12.055. View

20.

GUTHRIE H, Froozani M, Sherman A, BARRON G . Hyperlipidemia in offspring of iron-deficient rats. J Nutr. 1974; 104(10):1273-8. DOI: 10.1093/jn/104.10.1273. View